A case-based evaluation of personalized nutraceutical therapy in PCOD management
Authors/Creators
- 1. Sri Paripoorna Sanathana Ayurveda Medical College, Hospital and Research Centre, No. 91, Kaivalya Sannidhanam, Arjunabettahalli, Kasaba Hobli, Railway Gollahalli Post, Nelamangala Taluk, Bengaluru Rural India 562123.
- 2. Aspartika Biotech Pvt. Ltd., #7, DITPL, SW-51, Doddaballapura Industrial Area, Doddaballapura, Karnataka, India 561203.
- 3. Mallipathra Nutraceutical Pvt. Ltd., #25, 7th Cross, Nanjappa Layout, Vidyaranyapura, Bengaluru, Karnataka, India 560097
- 4. Someys Kitchen Pvt. Ltd., Marsandra, Doddaballapura Main Road, Doddaballapura, Karnataka, India 561203.
- 5. Sparsh the Wellness Clinique, 2110, 19th B Cross Rd, opp. Rangalakshmi Netralaya, next to Frank Ross Medical, MIG Sector B, Udaya Layout, Yelahanka New Town, Bengaluru, Karnataka, India 560064.
Description
Polycystic Ovary Disease (PCOD) is a complex endocrine disorder that significantly affects the reproductive and metabolic health of women. Conventional pharmacologic treatments often provide limited success in addressing underlying metabolic dysfunctions. This 12-week observational case study evaluated the effects of a personalized nutraceutical smoothie premix on three women clinically diagnosed with PCOD. The formulation integrated Ayurvedic botanicals, essential micronutrients, and functional food ingredients designed to support hormonal balance and enhance insulin sensitivity. Participants were monitored for clinical parameters, biochemical markers, and patient-reported outcomes at baseline and study completion. Notable improvements were observed in total testosterone levels (p<0.05), fasting insulin, and the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR). Additionally, participants reported enhanced overall well-being, improved energy levels, and better menstrual regularity. These preliminary findings suggest that personalized, integrative nutraceutical interventions may offer a promising adjunctive approach to managing PCOD by targeting its metabolic and hormonal dimensions.
Files
WJBPHS-2025-0386.pdf
Files
(493.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:0eadd986737da24612dbd668f5fc3fba
|
493.8 kB | Preview Download |